blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2182804

EP2182804 - METHODS FOR TREATING DEPENDENCE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.03.2018
Database last updated on 28.06.2024
FormerThe patent has been granted
Status updated on  21.04.2017
FormerGrant of patent is intended
Status updated on  18.11.2016
Most recent event   Tooltip29.05.2020Lapse of the patent in a contracting state
New state(s): PT		published on 01.07.2020  [2020/27]
Applicant(s)For all designated states
Biotie Therapies, Inc.
601 Gateway Boulevard, Suite 1200
South San Francisco, CA 94080 / US
[2011/50]
Former [2010/19]For all designated states
Synosia Therapeutics, Inc.
601 Gateway Boulevard Suite 1200
South San Francisco, CA 94080 / US
Inventor(s)01 / WOIWODE, Tom
c/o Biotie Therapies, Inc.
601 Gateway Boulevard
Suite 1200
South San Francisco, CA 94080 / US
02 / MORAN, Mark
c/o Biotie Therapies, Inc.
601 Gateway Boulevard
Suite 1200
South San Francisco, CA 94080 / US
03 / PICKFORD, Lesley
c/o Biotie Therapies, Inc.
601 Gateway Boulevard
Suite 1200
South San Francisco, CA 94080 / US
 [2012/02]
Former [2010/19]01 / WOIWODE, Tom
c/o Synosia Therapeutics Inc. 601 Gateway Boulevard Suite 1200
South San Francisco, CA 94080 / US
02 / MORAN, Mark
c/o Synosia Therapeutics Inc. 601 Gateway Boulevard Suite 1200
South San Francisco, CA 94080 / US
03 / PICKFORD, Lesley
c/o Synosia Therapeutics 601 Gateway Boulevard Suite 1200
South San Francisco, CA 94080 / US
Representative(s)Goodfellow, Hugh Robin, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2017/21]
Former [2010/19]Goodfellow, Hugh Robin, et al
Carpmaels & Ransford 43-45 Bloomsbury Square London
WC1A 2RA / GB
Application number, filing date08797300.406.08.2008
[2010/19]
WO2008US72357
Priority number, dateUS20070935323P06.08.2007         Original published format: US 935323 P
US20070956555P17.08.2007         Original published format: US 956555 P
US20070960591P04.10.2007         Original published format: US 960591 P
[2010/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009021055
Date:12.02.2009
Language:EN
[2009/07]
Type: A1 Application with search report 
No.:EP2182804
Date:12.05.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 12.02.2009 takes the place of the publication of the European patent application.
[2010/19]
Type: B1 Patent specification 
No.:EP2182804
Date:24.05.2017
Language:EN
[2017/21]
Search report(s)International search report - published on:US12.02.2009
(Supplementary) European search report - dispatched on:EP24.11.2010
ClassificationIPC:A61K31/415, A61K31/417, A61K9/08, A61K45/06, A61K31/4164, A61P25/30
[2016/46]
CPC:
A61K9/08 (EP,US); A61K31/417 (EP,CN,US); A61K31/4164 (US);
A61K31/415 (EP,US); A61K45/06 (US); A61P1/08 (EP);
A61P11/00 (EP); A61P11/02 (EP); A61P25/02 (EP);
A61P25/06 (EP); A61P25/08 (EP); A61P25/12 (EP);
A61P25/14 (EP); A61P25/18 (EP); A61P25/20 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P25/30 (EP); A61P25/32 (EP); A61P25/34 (EP);
A61P25/36 (EP); A61P43/00 (EP); A61P9/06 (EP);
A61P9/10 (EP) (-)
Former IPC [2010/51]A61K31/415, A61K31/417, A61P25/30
Former IPC [2010/19]A01N43/50, A61K31/415
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/21]
Former [2010/19]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON SUCHT[2010/19]
English:METHODS FOR TREATING DEPENDENCE[2010/19]
French:PROCÉDÉS DE TRAITEMENT D'UNE DÉPENDANCE[2010/19]
Entry into regional phase23.02.2010National basic fee paid 
23.02.2010Search fee paid 
23.02.2010Designation fee(s) paid 
23.02.2010Examination fee paid 
Examination procedure23.02.2010Examination requested  [2010/19]
24.06.2011Amendment by applicant (claims and/or description)
21.02.2014Despatch of a communication from the examining division (Time limit: M06)
26.09.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
08.12.2014Reply to a communication from the examining division
06.10.2016Cancellation of oral proceeding that was planned for 07.10.2016
07.10.2016Date of oral proceedings (cancelled)
28.11.2016Communication of intention to grant the patent
10.04.2017Fee for grant paid
10.04.2017Fee for publishing/printing paid
10.04.2017Receipt of the translation of the claim(s)
Divisional application(s)EP17165804.0  / EP3251670
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.02.2014
Opposition(s)27.02.2018No opposition filed within time limit [2018/18]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
08.12.2014Request for further processing filed
08.12.2014Full payment received (date of receipt of payment)
Request granted
17.12.2014Decision despatched
Fees paidRenewal fee
30.07.2010Renewal fee patent year 03
25.08.2011Renewal fee patent year 04
27.08.2012Renewal fee patent year 05
27.08.2013Renewal fee patent year 06
27.08.2014Renewal fee patent year 07
10.08.2015Renewal fee patent year 08
11.08.2016Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.08.2008
AT24.05.2017
CY24.05.2017
CZ24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
PL24.05.2017
PT24.05.2017
RO24.05.2017
SE24.05.2017
SI24.05.2017
SK24.05.2017
TR24.05.2017
IE06.08.2017
MT06.08.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
CH31.08.2017
LI31.08.2017
IS24.09.2017
[2020/27]
Former [2020/15]HU06.08.2008
AT24.05.2017
CY24.05.2017
CZ24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
PL24.05.2017
RO24.05.2017
SE24.05.2017
SI24.05.2017
SK24.05.2017
TR24.05.2017
IE06.08.2017
MT06.08.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
CH31.08.2017
LI31.08.2017
IS24.09.2017
Former [2019/46]HU06.08.2008
AT24.05.2017
CY24.05.2017
CZ24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
PL24.05.2017
RO24.05.2017
SE24.05.2017
SI24.05.2017
SK24.05.2017
IE06.08.2017
MT06.08.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
CH31.08.2017
LI31.08.2017
IS24.09.2017
Former [2019/31]HU06.08.2008
AT24.05.2017
CZ24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
PL24.05.2017
RO24.05.2017
SE24.05.2017
SI24.05.2017
SK24.05.2017
IE06.08.2017
MT06.08.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
CH31.08.2017
LI31.08.2017
IS24.09.2017
Former [2018/43]AT24.05.2017
CZ24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
PL24.05.2017
RO24.05.2017
SE24.05.2017
SI24.05.2017
SK24.05.2017
IE06.08.2017
MT06.08.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
CH31.08.2017
LI31.08.2017
IS24.09.2017
Former [2018/35]AT24.05.2017
CZ24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
PL24.05.2017
RO24.05.2017
SE24.05.2017
SI24.05.2017
SK24.05.2017
IE06.08.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
CH31.08.2017
LI31.08.2017
IS24.09.2017
Former [2018/25]AT24.05.2017
CZ24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
PL24.05.2017
RO24.05.2017
SE24.05.2017
SI24.05.2017
SK24.05.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
CH31.08.2017
LI31.08.2017
IS24.09.2017
Former [2018/21]AT24.05.2017
CZ24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
PL24.05.2017
RO24.05.2017
SE24.05.2017
SK24.05.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
CH31.08.2017
LI31.08.2017
IS24.09.2017
Former [2018/11]AT24.05.2017
CZ24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
PL24.05.2017
RO24.05.2017
SE24.05.2017
SK24.05.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
IS24.09.2017
Former [2018/10]AT24.05.2017
CZ24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
RO24.05.2017
SE24.05.2017
SK24.05.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
IS24.09.2017
Former [2018/09]AT24.05.2017
DK24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
SE24.05.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
IS24.09.2017
Former [2017/52]AT24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
NL24.05.2017
SE24.05.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
IS24.09.2017
Former [2017/50]AT24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
SE24.05.2017
BG24.08.2017
NO24.08.2017
GR25.08.2017
IS24.09.2017
Former [2017/49]AT24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
NO24.08.2017
GR25.08.2017
IS24.09.2017
Documents cited:Search[E]WO2009015248  (SYNOSIA THERAPEUTICS [US], et al) [E] 1,2,4-7,11,12,15 * page , paragraph [0199] * * page 26, paragraph [0281] * * claim 14 *;
 [Y]  - CUBELLS J F ET AL, "A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia", MOLECULAR PSYCHIATRY, (200001), vol. 5, no. 1, ISSN 1359-4184, pages 56 - 63, XP002609337 [Y] 1-27 * abstract * * page 61, column 2, paragraph 3 *
 [Y]  - PETRAKIS ISMENE L ET AL, "Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts", ADDICTION, (200002), vol. 95, no. 2, ISSN 0965-2140, pages 219 - 228, XP002609338 [Y] 1-27 * abstract *
 [Y]  - STANLEY WILLIAM C ET AL, "Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase", BRITISH JOURNAL OF PHARMACOLOGY, (1997), vol. 121, no. 8, ISSN 0007-1188, pages 1803 - 1809, XP002609339 [Y] 1-27 * abstract *
International search[Y]US5593367  (EAVENSON SR JIMMY N [US], et al);
 [Y]US5958896  (RENSHAW PERRY F [US], et al);
 [Y]US2003040015  (KIM KWANG-SOO [US], et al);
 [Y]US2006058336  (NAKANISHI SHIGETADA [JP], et al);
 [Y]  - NICH ET AL., "Sex differences in cocaine-dependent individuals' response to disulfiram treatment", ADDICTIVE BEHAVIORS, (2004), vol. 29, pages 1123 - 1128, XP008129900

DOI:   http://dx.doi.org/10.1016/j.addbeh.2004.03.004
by applicant   - PETRAKIS ET AL., ADDICTION, (2000), vol. 95, no. 2, pages 219 - 228
    - CUBELLS ET AL., MOLECULAR PSYCHIATRY, (2000), vol. 5, pages 56 - 63
    - STANLEY ET AL., BRITISH JOURNAL OF PHARMACOLOGY, (1997), vol. 121, pages 1803 - 1809
    - FEILCHENFELD, N.B.; RICHTER, H.; WADDELL, W.H., ANAL. BIOCHEM: A TIME-RESOLVED ASSAY OF DOPAMINE ?-HYDROXYLASE ACTIVITY UTILIZATING HIGH-PRESSURE LIQUID CHROMATOGRAPHY, (1982), vol. 122, pages 124 - 128
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.